|
Market Closed -
Nasdaq
16:00:00 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 16.56 USD | -2.07% |
|
-13.30% | +43.13% |
Company Valuation: Sutro Biopharma, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 688.5 | 464.4 | 261.5 | 151.7 | 98.57 | 274.6 | - | - |
| Change | - | -32.55% | -43.69% | -41.98% | -35.03% | 178.57% | - | - |
| Enterprise Value (EV) | 552 | 179.6 | 196.3 | -38.58 | -42.86 | 274.6 | 274.6 | 274.6 |
| Change | - | -67.46% | 9.29% | -119.66% | -11.09% | 740.67% | 0% | 0% |
| P/E | -6.5x | -3.44x | -2.41x | -0.62x | -0.51x | -2.01x | -2.51x | -2.53x |
| PBR | - | - | 1.75x | 3.4x | -7.5x | - | - | - |
| PEG | - | -1.31x | 0.1x | -0x | 0x | 0x | 0.1x | 2.64x |
| Capitalization / Revenue | 11.1x | 6.85x | 1.7x | 2.45x | 0.96x | 5.33x | 8.69x | 10.8x |
| EV / Revenue | 0x | 0x | 0x | -0x | -0x | 5.33x | 8.69x | 10.8x |
| EV / EBITDA | -0x | -0x | - | 0x | 0x | -2.76x | -2.57x | -2.11x |
| EV / EBIT | -0x | -0x | -0x | 0x | 0x | -2.42x | -2.28x | -1.83x |
| EV / FCF | -0x | -0x | -0x | 0x | 0x | -2.72x | -2.49x | -1.79x |
| FCF Yield | -14.1% | -0.93% | -44.3% | -128% | -182% | -36.7% | -40.2% | -55.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -22.9 | -23.5 | -17.8 | -29.6 | -22.49 | -8.23 | -6.608 | -6.544 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 61.88 | 67.77 | 153.7 | 62.04 | 102.5 | 51.55 | 31.59 | 25.44 |
| EBITDA 1 | -93.68 | -123.3 | - | -231.2 | -97.63 | -99.51 | -106.8 | -130.4 |
| EBIT 1 | -98.52 | -128.9 | -89.28 | -238.5 | -105 | -113.3 | -120.3 | -150.1 |
| Net income 1 | -105.5 | -119.2 | -106.8 | -227.5 | -191.1 | -129.5 | -140.7 | -153.5 |
| Net Debt | -136.5 | -284.8 | -65.21 | -190.3 | -141.4 | - | - | - |
| Reference price 2 | 148.80 | 80.80 | 42.90 | 18.40 | 11.57 | 16.56 | 16.56 | 16.56 |
| Nbr of stocks (in thousands) | 4,627 | 5,748 | 6,095 | 8,246 | 8,519 | 16,581 | - | - |
| Announcement Date | 2/28/22 | 3/30/23 | 3/25/24 | 3/13/25 | 3/23/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.05x | - | - | -.--% | 280M | |
| 20.63x | 7.28x | 14.62x | 1.44% | 70.24B | |
| 32.28x | 9.34x | 45.05x | 0.04% | 62.63B | |
| -76.7x | 14.8x | -71.37x | -.--% | 27.36B | |
| 29.77x | 6.32x | 16.41x | -.--% | 25.71B | |
| -15.03x | 5.62x | -7.06x | -.--% | 24.83B | |
| 26.45x | 5.03x | 16.73x | -.--% | 19.52B | |
| 44.88x | 16.47x | 33.42x | 0.34% | 15.51B | |
| 1267.62x | 36.68x | 797.93x | -.--% | 14.66B | |
| -15.8x | 3569.89x | -18.25x | -.--% | 14.69B | |
| Average | 131.21x | 407.94x | 91.94x | 0.18% | 27.54B | |
| Weighted average by Cap. | 77.45x | 200.44x | 52.40x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- STRO Stock
- Valuation Sutro Biopharma, Inc.
Select your edition
All financial news and data tailored to specific country editions
